NVIGEN is a nanobiotechnology company revolutionizing the field of multifunctional nanoparticles for biomedical applications. Their pipeline of visionary solutions stems from our proprietary nanochemistry technology. NVIGEN was founded in the heart of Silicon Valley, from technologies that culminated from years of rigorous research at the University of California, Berkeley, and Stanford University.
NVIGEN develops nanoparticle research reagents and devices for biomedical research applications. NVIGEN was incorporated in 2011.